UBS reiterates its Buy recommendation on the share, but lowers its target price to E7.75 (from E8.25), which still represents a potential upside of 20%.

''Q4 results are solid, but macroeconomic uncertainty weighs on near-term revenue growth expectations'' says UBS.

For 2024, Nexi expects mid-single-digit year-on-year growth, mid- to high-single-digit year-on-year EBITDA, and excess cash generation of over 700 million euros.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.